102 results
S-1/A
EX-10.26
MRVI
Maravai LifeSciences Holdings Inc - Ordinary Shares
9 Nov 20
IPO registration (amended)
2:05pm
, data warehouse and methodologies, all proprietary information, know-how, trade secrets, technical and non-technical materials, products … discharge or Release of pollutants or Hazardous Materials; (v) the conduct of environmental impact assessment in connection with the design, development
S-1
EX-10.18
MRVI
Maravai LifeSciences Holdings Inc - Ordinary Shares
29 Oct 20
IPO registration
5:04pm
(continued)
Page
Laws/CC&&R’s
Hazardous Materials
Odors and Exhaust
ARTICLE 9
MOLD
ARTICLE 10
NOTICES
Method of Delivery
Receipt of Notices
Statutory … equipment, systems or materials needed to operate the Project or any portion thereof at the same quality levels as prior to the improvement
S-1
EX-10.19
MRVI
Maravai LifeSciences Holdings Inc - Ordinary Shares
29 Oct 20
IPO registration
5:04pm
referred to as the “Real Estate Taxes”). Lessee shall pay any and all personal property taxes.
HAZARDOUS MATERIALS AND ENVIRONMENTAL LAWS. Lessee … or materials as such materials are defined in RCRA, CERCLA (Super Fund), and North Carolina’s Oil Pollution and Hazardous Substances Control Act
S-1
EX-10.16
MRVI
Maravai LifeSciences Holdings Inc - Ordinary Shares
29 Oct 20
IPO registration
5:04pm
Description of the Land
Exhibit B Outline of the Premises
Exhibit C List of Approved Contractors
Exhibit D Permitted Materials
Exhibit E Guaranty … service, waste pick up, and any other utilities, materials or services furnished directly to or used by Tenant on or about the Premises during
DRS/A
EX-10.18
r1uocaff8ow9
14 Oct 20
Draft registration statement (amended)
12:00am
DRS/A
EX-10.19
an3pidj263
14 Oct 20
Draft registration statement (amended)
12:00am
DRS/A
EX-10.16
696oh5i
14 Oct 20
Draft registration statement (amended)
12:00am
DEF 14A
kzv4 m5oolbc
19 Apr 21
Definitive proxy
4:46pm
PRE 14A
azqaust47ulp023ct8q
9 Apr 21
Preliminary proxy
4:16pm
DRS/A
EX-10.15
3czb x8jd11s0
14 Oct 20
Draft registration statement (amended)
12:00am
DRSLTR
o2l x9c65a6w6rbx
14 Oct 20
Correspondence regarding draft registration statement
12:00am
8-K
EX-10.5
j3ghv0olcfgdkk8y0nc
25 Nov 20
Maravai LifeSciences Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to
8:03am
8-K
8ult5d 03n26gj08uem
5 Apr 21
Maravai Lifesciences Announces Preliminary Unaudited First Quarter Revenues and Income from Operations Range
5:15pm
S-1
EX-10.25
etwx17u50i 0uy9fag
29 Oct 20
IPO registration
5:04pm
S-1
EX-10.15
b95sysplffgiypfns
29 Oct 20
IPO registration
5:04pm
DRS
kw8jpux46hxi0b8
8 Sep 20
Draft registration statement
12:00am